Bayesian Capital Management, LP Annexon, Inc. Transaction History
Bayesian Capital Management, LP
- $854 Million
- Q2 2024
A detailed history of Bayesian Capital Management, LP transactions in Annexon, Inc. stock. As of the latest transaction made, Bayesian Capital Management, LP holds 38,599 shares of ANNX stock, worth $271,350. This represents 0.02% of its overall portfolio holdings.
Number of Shares
38,599
Previous 16,599
132.54%
Holding current value
$271,350
Previous $119,000
58.82%
% of portfolio
0.02%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding ANNX
# of Institutions
156Shares Held
101MCall Options Held
3.73MPut Options Held
1.3M-
Bain Capital Life Sciences Investors, LLC Boston, MA8.45MShares$59.4 Million8.47% of portfolio
-
Satter Management Co., L.P.7.41MShares$52.1 Million71.21% of portfolio
-
Bvf Inc San Francisco, CA7MShares$49.2 Million1.05% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$46.3 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.43MShares$45.2 Million2.05% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $335M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...